A Mutation in the 16S rRNA Decoding Region Attenuates the Virulence of Mycobacterium tuberculosis
- PMID: 27245411
- PMCID: PMC4962622
- DOI: 10.1128/IAI.00417-16
A Mutation in the 16S rRNA Decoding Region Attenuates the Virulence of Mycobacterium tuberculosis
Abstract
Mycobacterium tuberculosis contains a single rRNA operon that encodes targets for antituberculosis agents, including kanamycin. To date, only four mutations in the kanamycin binding sites of 16S rRNA have been reported in kanamycin-resistant clinical isolates. We hypothesized that another mutation(s) in the region may dramatically decrease M. tuberculosis viability and virulence. Here, we describe an rRNA mutation, U1406A, which was generated in vitro and confers resistance to kanamycin while highly attenuating M. tuberculosis virulence. The mutant showed decreased expression of 20% (n = 361) of mycobacterial proteins, including central metabolic enzymes, mycolic acid biosynthesis enzymes, and virulence factors such as antigen 85 complexes and ESAT-6. The mutation also induced three proteins, including KsgA (Rv1010; 16S rRNA adenine dimethyltransferase), which closely bind to the U1406A mutation site on the ribosome; these proteins were associated with ribosome maturation and translation initiation processes. The mutant showed an increase in 17S rRNA (precursor 16S rRNA) and a decrease in the ratio of 30S subunits to the 70S ribosomes, suggesting that the U1406A mutation in 16S rRNA attenuated M. tuberculosis virulence by affecting these processes.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.
Figures
![FIG 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4962622/bin/zii9990917740001.gif)
![FIG 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4962622/bin/zii9990917740002.gif)
![FIG 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4962622/bin/zii9990917740003.gif)
![FIG 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4962622/bin/zii9990917740004.gif)
![FIG 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4962622/bin/zii9990917740005.gif)
![FIG 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4962622/bin/zii9990917740006.gif)
![FIG 7](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4962622/bin/zii9990917740007.gif)
Similar articles
-
A role for 16S rRNA dimethyltransferase (ksgA) in intrinsic clarithromycin resistance in Mycobacterium tuberculosis.Int J Antimicrob Agents. 2013 Jun;41(6):548-51. doi: 10.1016/j.ijantimicag.2013.02.011. Epub 2013 Mar 27. Int J Antimicrob Agents. 2013. PMID: 23541074
-
Comparison of clinical isolates and in vitro selected mutants reveals that tlyA is not a sensitive genetic marker for capreomycin resistance in Mycobacterium tuberculosis.J Antimicrob Chemother. 2011 Jun;66(6):1247-54. doi: 10.1093/jac/dkr109. Epub 2011 Mar 21. J Antimicrob Chemother. 2011. PMID: 21427106
-
Mycobacterium tuberculosis rrs A1401G mutation correlates with high-level resistance to kanamycin, amikacin, and capreomycin in clinical isolates from mainland China.Diagn Microbiol Infect Dis. 2013 Oct;77(2):138-42. doi: 10.1016/j.diagmicrobio.2013.06.031. Epub 2013 Aug 12. Diagn Microbiol Infect Dis. 2013. PMID: 23948547
-
Impact of isoniazid resistance on virulence of global and south Indian clinical isolates of Mycobacterium tuberculosis.Tuberculosis (Edinb). 2014 Dec;94(6):557-63. doi: 10.1016/j.tube.2014.08.011. Epub 2014 Sep 6. Tuberculosis (Edinb). 2014. PMID: 25270728 Review.
-
Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update.Tuber Lung Dis. 1998;79(1):3-29. doi: 10.1054/tuld.1998.0002. Tuber Lung Dis. 1998. PMID: 10645439 Review.
Cited by
-
Protein translation: biological processes and therapeutic strategies for human diseases.Signal Transduct Target Ther. 2024 Feb 23;9(1):44. doi: 10.1038/s41392-024-01749-9. Signal Transduct Target Ther. 2024. PMID: 38388452 Free PMC article. Review.
-
Overcoming Mycobacterium tuberculosis through small molecule inhibitors to break down cell wall synthesis.Acta Pharm Sin B. 2022 Aug;12(8):3201-3214. doi: 10.1016/j.apsb.2022.04.014. Epub 2022 Apr 27. Acta Pharm Sin B. 2022. PMID: 35967276 Free PMC article. Review.
-
Studies on Aminoglycoside Susceptibility Identify a Novel Function of KsgA To Secure Translational Fidelity during Antibiotic Stress.Antimicrob Agents Chemother. 2018 Sep 24;62(10):e00853-18. doi: 10.1128/AAC.00853-18. Print 2018 Oct. Antimicrob Agents Chemother. 2018. PMID: 30082289 Free PMC article.
References
-
- World Health Organization. 2015. Global tuberculosis report 2015. World Health Organization, Geneva, Switzerland.
-
- Nathanson E, Lambregts-van Weezenbeek C, Rich ML, Gupta R, Bayona J, Blondal K, Caminero JA, Cegielski JP, Danilovits M, Espinal MA, Hollo V, Jaramillo E, Leimane V, Mitnick CD, Mukherjee JS, Nunn P, Pasechnikov A, Tupasi T, Wells C, Raviglione MC. 2006. Multidrug-resistant tuberculosis management in resource-limited settings. Emerg Infect Dis 12:1389–1397. doi:10.3201/eid1209.051618. - DOI - PMC - PubMed
-
- Shah NS, Wright A, Bai GH, Barrera L, Boulahbal F, Martin-Casabona N, Drobniewski F, Gilpin C, Havelkova M, Lepe R, Lumb R, Metchock B, Portaels F, Rodrigues MF, Rusch-Gerdes S, Van Deun A, Vincent V, Laserson K, Wells C, Cegielski JP. 2007. Worldwide emergence of extensively drug-resistant tuberculosis. Emerg Infect Dis 13:380–387. doi:10.3201/eid1303.061400. - DOI - PMC - PubMed
-
- Reeves AZ, Campbell PJ, Sultana R, Malik S, Murray M, Plikaytis BB, Shinnick TM, Posey JE. 2013. Aminoglycoside cross-resistance in Mycobacterium tuberculosis due to mutations in the 5′ untranslated region of whiB7. Antimicrob Agents Chemother 57:1857–1865. doi:10.1128/AAC.02191-12. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources